Andreas Kogelnik: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
VisualWikitext
(reformatted study section & ref)
(working group; chronology)
Line 7: Line 7:
*Residency in Internal Medicine at Stanford University
*Residency in Internal Medicine at Stanford University
*Fellowship in Infectious Diseases at Stanford University
*Fellowship in Infectious Diseases at Stanford University
==ME/CFS Common Data Element (CDE) Project==
Member of the Immune Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].<ref>https://www.commondataelements.ninds.nih.gov/ReportViewer.aspx?%2fnindscdereports%2fRoster&rs%3aCommand=Render&rc:Parameters=false&diseaseid=MECFS&custom:disableExcel=true&custom:disableXML=true&custom:disableCSV=true</ref>


==Research publications on ME/CFS==
==Research publications on ME/CFS==
*2017, Multi-Site Clinical Assessment of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017"/> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565838/ (Full Text)]
*2013, Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.<ref>Montoya JG, Kogelnik AM, Bhangoo M, Lunn MR, Flamand L, Merrihew LE, Watt T, Kubo JT, Paik J, Desai M.(2013). Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. ''Journal of Medical Virology,85'' (12):2101-9. doi: 10.1002/jmv.23713. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23959519</ref>
*2011, No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected.<ref>Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J Jr, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA.(2011). No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. ''Science,333'' (6038):94-7. doi: 10.1126/science.1204963. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21628393</ref>
*2006, Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.<ref>Kogelnik AM, Loomis K, Hoegh-Petersen M, Rosso F, Hischier C, Montoya JG. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. ''Journal of Clinical Virology,37'' Suppl 1:S33-8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed
*2006, Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.<ref>Kogelnik AM, Loomis K, Hoegh-Petersen M, Rosso F, Hischier C, Montoya JG. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. ''Journal of Clinical Virology,37'' Suppl 1:S33-8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed
/17276366</ref>
/17276366</ref>
*2011, No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected.<ref>Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J Jr, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA.(2011). No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. ''Science,333'' (6038):94-7. doi: 10.1126/science.1204963. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21628393</ref>
*2013, Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.<ref>Montoya JG, Kogelnik AM, Bhangoo M, Lunn MR, Flamand L, Merrihew LE, Watt T, Kubo JT, Paik J, Desai M.(2013). Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. ''Journal of Medical Virology,85'' (12):2101-9. doi: 10.1002/jmv.23713. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23959519</ref>
*2017, Multi-Site Clinical Assessment of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017"/> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565838/ (Full Text)]


==Articles==
==Articles==
Line 19: Line 22:


==Talks and Interviews==
==Talks and Interviews==
*2014, [https://www.youtube.com/watch?v=TXfx5dzRQwk  YouTube - ''What Works For Chronic Fatigue Syndrome'']
*May 2011 - Keynote Speaker at the 6th [[Invest in ME International ME Conference]] - Speech Title: ''Strategies for ME Research and Collaboration''<ref>http://www.investinme.eu/IIMEC6.shtml#agenda</ref>
*2014, [http://www.investinme.eu/IIMEC9.shtml 9th [[Invest in ME International ME Conference]] 2014 - No title of talk given]
:*[http://www.investinme.eu/IIMEC6.shtml#dvd 2011 Conference DVD]
:*[http://www.investinme.eu/IIMEC9.shtml#dvd 2014 Conference DVD]
*2014, [[ME/CFS Alert]] Episode 56: [https://www.youtube.com/watch?v=ap5dzdXuDBc Dr. Andreas Kogelnik on the "Real Thrust" of ME/CFS Research]
*2014, [[ME/CFS Alert]] Episode 55: [https://www.youtube.com/watch?v=sbHtPVXVAIY Interview with Dr. Andreas Kogelnik]
*17 Feb 2014, [https://soundcloud.com/ryan-prior-1/dr-andy-kogelnik-and-llewellyn Dr. Andreas Kogelnik and [[Llewellyn King]] on Sirius XM Radio POTUS Channel 124]
*23 Jan 2014, [https://soundcloud.com/ryan-prior-1/jimbo Dr. Andreas Kogelnik, [[Ryan Prior]] and [[Llewellyn King]] appeared on “The Jim Bohannon Show”]
*2013, 8th [[Invest in ME International ME Conference]] Keynote Speaker: ''Strategies for ME Research and Collaboration''<ref>http://www.investinme.eu/IIMEC8.shtml</ref>
:*[http://www.investinme.eu/IIMEC8.shtml#dvd 2013 Conference DVD]
*2012, [[ME/CFS Alert]] Episode 23:  
*2012, [[ME/CFS Alert]] Episode 23:  
:[https://www.youtube.com/watch?v=Dt8hKslAVk8 The Open Medicine Institute, Part 1],
:[https://www.youtube.com/watch?v=Dt8hKslAVk8 The Open Medicine Institute, Part 1],
Line 37: Line 33:
*2012, 7th [[Invest in ME International ME Conference]] - ''Strategies for ME Research and Collaboration''<ref>http://www.investinme.eu/IIMEC7.shtml</ref>
*2012, 7th [[Invest in ME International ME Conference]] - ''Strategies for ME Research and Collaboration''<ref>http://www.investinme.eu/IIMEC7.shtml</ref>
:*[http://www.investinme.eu/IIMEC7.shtml#dvd 2012 Conference DVD]
:*[http://www.investinme.eu/IIMEC7.shtml#dvd 2012 Conference DVD]
*May 2011 - Keynote Speaker at the 6th [[Invest in ME International ME Conference]] - Speech Title: ''Strategies for ME Research and Collaboration''<ref>http://www.investinme.eu/IIMEC6.shtml#agenda</ref>
*2013, 8th [[Invest in ME International ME Conference]] Keynote Speaker: ''Strategies for ME Research and Collaboration''<ref>http://www.investinme.eu/IIMEC8.shtml</ref>
:*[http://www.investinme.eu/IIMEC6.shtml#dvd 2011 Conference DVD]
:*[http://www.investinme.eu/IIMEC8.shtml#dvd 2013 Conference DVD]
*2014, [https://www.youtube.com/watch?v=TXfx5dzRQwk  YouTube - ''What Works For Chronic Fatigue Syndrome'']
*2014, [http://www.investinme.eu/IIMEC9.shtml 9th [[Invest in ME International ME Conference]] 2014 - No title of talk given]
:*[http://www.investinme.eu/IIMEC9.shtml#dvd 2014 Conference DVD]
*2014, [[ME/CFS Alert]] Episode 56: [https://www.youtube.com/watch?v=ap5dzdXuDBc Dr. Andreas Kogelnik on the "Real Thrust" of ME/CFS Research]
*2014, [[ME/CFS Alert]] Episode 55: [https://www.youtube.com/watch?v=sbHtPVXVAIY Interview with Dr. Andreas Kogelnik]
*17 Feb 2014, [https://soundcloud.com/ryan-prior-1/dr-andy-kogelnik-and-llewellyn Dr. Andreas Kogelnik and [[Llewellyn King]] on Sirius XM Radio POTUS Channel 124]
*23 Jan 2014, [https://soundcloud.com/ryan-prior-1/jimbo Dr. Andreas Kogelnik, [[Ryan Prior]] and [[Llewellyn King]] appeared on “The Jim Bohannon Show”


==References==
==References==

Revision as of 14:13, June 23, 2018

Source: www.openmedicinefoundation.org

Andreas M. Kogelnik, ("Andy") MD, PhD., is an Internal Medicine and Infectious Diseases specialist, the director of the Open Medicine Institute, Mountain View, California, USA, and a member of the Scientific Advisory Board for the Open Medicine Foundation, Agoura Hills, CA.[1][2] His interests are in the bioinformatics and genomic revolution in medicine and is committed to the study of and treatment of ME/CFS and other chronic illnesses.[3][4]

Education[edit | edit source]

  • MD from Emory University
  • PhD in bioengineering from Georgia Tech
  • Residency in Internal Medicine at Stanford University
  • Fellowship in Infectious Diseases at Stanford University

ME/CFS Common Data Element (CDE) Project[edit | edit source]

Member of the Immune Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.[5]

Research publications on ME/CFS[edit | edit source]

  • 2006, Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.[6]
  • 2011, No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected.[7]
  • 2013, Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.[8]
  • 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[9] (Full Text)

Articles[edit | edit source]

Talks and Interviews[edit | edit source]

The Open Medicine Institute, Part 1,
The Open Medicine Institute, Part 2,
The Open Medicine Institute, Part 3
Interview with Dr. Andreas Kogelnik, Part 1
Interview with Dr. Andreas Kogelnik, Part 2

References[edit | edit source]

  1. ↑ http://www.openmedicineinstitute.org/the-clinic.html
  2. ↑ http://www.openmedicinefoundation.org/scientific-advisory-board/
  3. ↑ http://www.openmedicineinstitute.org/the-clinic.html
  4. ↑ http://www.openmedicinefoundation.org/scientific-advisory-board/
  5. ↑ https://www.commondataelements.ninds.nih.gov/ReportViewer.aspx?%2fnindscdereports%2fRoster&rs%3aCommand=Render&rc:Parameters=false&diseaseid=MECFS&custom:disableExcel=true&custom:disableXML=true&custom:disableCSV=true
  6. ↑ Kogelnik AM, Loomis K, Hoegh-Petersen M, Rosso F, Hischier C, Montoya JG. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. Journal of Clinical Virology,37 Suppl 1:S33-8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed /17276366
  7. ↑ Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J Jr, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA.(2011). No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science,333 (6038):94-7. doi: 10.1126/science.1204963. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21628393
  8. ↑ Montoya JG, Kogelnik AM, Bhangoo M, Lunn MR, Flamand L, Merrihew LE, Watt T, Kubo JT, Paik J, Desai M.(2013). Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. Journal of Medical Virology,85 (12):2101-9. doi: 10.1002/jmv.23713. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23959519
  9. ↑ Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
  10. ↑ http://www.investinme.eu/IIMEC6.shtml#agenda
  11. ↑ http://www.investinme.eu/IIMEC7.shtml
  12. ↑ http://www.investinme.eu/IIMEC8.shtml

chronic illness any long-term illness, regardless of the severity. Chronic illnesses are typically incurable, requiring long-term management.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

central nervous system (CNS) - One of the two parts of the human nervous system, the other part being the peripheral nervous system. The central nervous system consists of the brain and spinal cord, while the peripheral nervous system consists of nerves that travel from the central nervous system into the various organs and tissues of the body.

Retrieved from "https://me-pedia.org/w/index.php?title=Andreas_Kogelnik&oldid=32570"